Home/Filings/4/0001209191-23-007511
4//SEC Filing

Valamehr Bahram 4

Accession 0001209191-23-007511

CIK 0001434316other

Filed

Feb 6, 7:00 PM ET

Accepted

Feb 7, 4:20 PM ET

Size

5.5 KB

Accession

0001209191-23-007511

Insider Transaction Report

Form 4
Period: 2023-02-06
Valamehr Bahram
DirectorPresident and CEO
Transactions
  • Award

    Stock Option (Right to Buy)

    2023-02-06+450,000450,000 total
    Exercise: $6.77Exp: 2033-02-05Common Stock (450,000 underlying)
Footnotes (1)
  • [F1]The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2023, such that all of the shares shall be fully vested and exercisable on January 1, 2026, subject to the Reporting Person's continued service with the Issuer as of each such vesting date.

Issuer

FATE THERAPEUTICS INC

CIK 0001434316

Entity typeother

Related Parties

1
  • filerCIK 0001748177

Filing Metadata

Form type
4
Filed
Feb 6, 7:00 PM ET
Accepted
Feb 7, 4:20 PM ET
Size
5.5 KB